Generated: December 15, 2017
DrugPatentWatch Database Preview
Details for Patent: 8,003,673
« Back to Dashboard
Which drugs does patent 8,003,673 protect, and when does it expire?
Summary for Patent: 8,003,673
|Title:||Daptomycin for the treatment of biofilm and catheter salvage|
|Abstract:|| Daptomycin can be used for biofilm treatment (particularly central venous catheter salvage for S. epidermidis infected catheters). Catheter salvage with daptomycin shows rapid cidality, activity against stationary phase bacteria, and penetration and activity in biofilms. The present inventions provide formulations, methods, and articles of manufacture useful for biofilm treatment or catheter salvage involving daptomycin. Particular formulations include daptomycin in lactated Ringer's solution having a rapid kill curve against the bacteria of the biofilm.|
|Inventor(s):|| Alder; Jeffrey (Harvard, MA), Silverman; Jared (Brookline, MA), Mortin; Lawrence (Framingham, MA), Van Praagh; Andrew (Chelmsford, MA) |
|Assignee:|| Cubist Pharmaceuticals, Inc. (Lexington, MA) |
Patent Claim Types:|
see list of patent claims
|Use; Formulation; Device; |
||Patented / Exclusive Use
|Cubist Pharms Llc||CUBICIN||daptomycin||POWDER;INTRAVENOUS||021572-002||Sep 12, 2003||AP||RX||Yes||Yes||► Subscribe||► Subscribe||TREATMENT OF THE FOLLOWING INFECTIONS: COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS AND STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BACTEREMIA) INCLUDING THOSE WITH RIGHT-SIDED INFECTIVE ENDOCARDITIS||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Foreign Priority and PCT Information for Patent: 8,003,673
|PCT Filed||May 31, 2006||PCT Application Number:||PCT/US2006/021006|
|PCT Publication Date:||December 07, 2006||PCT Publication Number:||
International Patent Family for Patent: 8,003,673
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.